tradingkey.logo
tradingkey.logo
Search

Kyverna Therapeutics Inc

KYTX
Add to Watchlist
8.890USD
+0.450+5.33%
Close 07/02, 13:00ETQuotes delayed by 15 min
538.13MMarket Cap
LossP/E TTM

Kyverna Therapeutics Inc Earnings Date

Period
FY2025 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-3.64
-9.60%
Analyst Rating
BUY
2026-07-05

Financial Indicators

EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Income Statement

Revenue
Operating profit
Net Profit
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Balance Sheet

Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Cash Flow Statement

Net operating income
Net investment
Net financing
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

FAQs

What are the current assets of Kyverna Therapeutics Inc?

According to Kyverna Therapeutics Inc's FY2025 earnings report, its current assets were 282.95M, with a year-on-year change of -2.63.

What are the total assets of Kyverna Therapeutics Inc?

According to Kyverna Therapeutics Inc's FY2025 earnings report, its total assets of Kyverna Therapeutics Inc were 293.83M, with a year-on-year change of -3.55.

What are the total liabilities of Kyverna Therapeutics Inc?

According to Kyverna Therapeutics Inc's FY2025 earnings report, its total liabilities of Kyverna Therapeutics Inc were 61.55M, with a year-on-year change of 61.73.

What is the total equity of Kyverna Therapeutics Inc?

According to Kyverna Therapeutics Inc's FY2025 earnings report, its total equity of Kyverna Therapeutics Inc was 232.28M, with a year-on-year change of -12.87.

What is the net investment of Kyverna Therapeutics Inc?

According to Kyverna Therapeutics Inc's FY2025 earnings report, its net investment of Kyverna Therapeutics Inc was 40.02M, with a year-on-year change of 124.87.

What is the net financing of Kyverna Therapeutics Inc?

According to Kyverna Therapeutics Inc's FY2025 earnings report, its net financing of Kyverna Therapeutics Inc was 141.17M, with a year-on-year change of -58.12.

What is the Earnings Per Share (EPS) of Kyverna Therapeutics Inc?

According to Kyverna Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -3.64, with a year-on-year change of -9.60.

What is the debt-to-asset ratio of Kyverna Therapeutics Inc?

According to Kyverna Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 8.53, with a year-on-year change of 2720.10.

What is the Return on Equity (ROE) of Kyverna Therapeutics Inc?

According to Kyverna Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -64.67, with a year-on-year change of 65.71.

What is the Return on Assets (ROA) of Kyverna Therapeutics Inc?

According to Kyverna Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -53.91, with a year-on-year change of 19.69.

What is the operating profit of Kyverna Therapeutics Inc?

According to Kyverna Therapeutics Inc's FY2025 earnings report, its operating profit was -169.23M, with a year-on-year change of -18.67.